Health
Clinical efficacy and safety of neratinib for breast cancer | DDDT – Dove Medical Press
Clinical efficacy & safety of neratinib for the treatment of adult patients with advanced or metastatic HER2 positive breast…
Introduction
Breast cancer is the most common malignancy in women (approximately 30% of total), where it represents the first cause of cancer-related death.1
From a biological point of view, breast cancer can be classified into molecularly defined subtypes,…
Continue Reading
-
General8 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News10 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
General23 hours agoWest Indies vs Australia live: Second Test, day three from Grenada
-
General22 hours agoDr Daniel Hunt, Michael Long and Christine Anu celebrated at 50th NAIDOC Week Awards